Thank You for Your Interest In Our Seasonal Flu Vaccine Clinical Trial - Don’t Miss Our Next Study!
Thank you for your interest in our seasonal flu vaccine clinical trial. We appreciate your commitment to advancing medical research. Due to the overwhelming response, enrolment for the flu vaccine trial has now closed.
We are excited to inform you about a new opportunity to participate in our Norovirus Vaccine Clinical Trial. This study aims to evaluate the safety and effectiveness of a Norovirus vaccine for adults aged 60 to 80. Norovirus is a highly contagious virus that causes sudden onset of severe stomach pain, nausea, vomiting, and diarrhoea. It affects millions of people globally every year, and there’s currently no vaccine available.
About the Study:
- Who Can Join? Adults aged 60 to 80 years old.
- What’s Involved? Participants will complete up to 7 scheduled clinic visits over a 2-year period.
- Compensation: Volunteers will receive travel reimbursement and compensation for their participation.
Eligibility Requirements:
To be eligible, you must be:
- Between 60 and 80 years old.
You may not be eligible if you:
- Have had acute gastroenteritis within 14 days before your first clinic visit (if you’ve been sick recently, you may still qualify at a later date).
- Have a reported history of substance abuse.
- Have a reported history of congenital or acquired immunodeficiency.
- Have participated in another clinical study within 90 days prior to your first clinic visit.
By joining this trial, you’ll contribute to investigational research focused on the first vaccine for Norovirus. As a participant, you will receive compensation for your participation and reimbursement for travel expenses related to clinic visits.
To learn more or to determine your eligibility, please visit our web site for more information about our Norovirus Vaccine Clinical Trial.
If you have any questions or need further assistance, please don’t hesitate to contact us at [email protected] or call us at 03300 553327.